EU Epidemiological Surveillance Regulation Amendment: What Changes for Hospitals and Laboratories

Key data

Epidemiological surveillance systems in Spain and throughout the EU operate under a common regulatory framework that has just been amended. Implementing Regulation (EU) 2026/2097, approved on 18 September 2026 and which repealed the previous Implementing Decision (EU) 2018/945, now receives an official amendment published on 10 November 2026. This amendment may affect technical case definitions, the list of communicable diseases subject to mandatory notification, or reporting procedures to the ECDC.

For hospitals, clinical laboratories and health authorities, this is not a minor change: the exact criteria by which a "confirmed case", a "probable case" or a "possible case" is defined determine what data is reported, when and through which channels. A mismatch between internal protocols and the amended terms can generate underreporting or overreporting to European authorities.

What does this regulation establish?

Implementing Regulation (EU) 2026/2097 establishes three fundamental elements for epidemiological surveillance in the European Union:

• List of communicable diseases subject to mandatory epidemiological surveillance in all Member States.
• Case definitions for each disease included in the list, which determine when a patient should be reported as a confirmed, probable or possible case.
• Special health risks associated with such diseases, which trigger specific response protocols.

This regulation replaced and repealed the Implementing Decision (EU) 2018/945, which had been the reference framework for nearly a decade. The amendment now published modifies specific aspects of the text approved in September 2026, although the available data do not specify which specific articles or annexes are subject to the amendment.

The change in regulatory rank—from Decision to Regulation—is relevant: an Implementing Regulation is directly applicable in all Member States without the need for national transposition, which reinforces the obligation of uniform compliance.

Economic and operational impact

The direct impact of this amendment is operational and compliance-related, not economic in terms of quantified fees or sanctions in the available data. However, the practical consequences for affected organizations are concrete:

• Update of health information systems: Hospitals and laboratories that report cases to regional and national surveillance networks must verify that their systems collect data in accordance with the amended case definitions.
• Review of internal protocols: Preventive medicine, microbiology and hospital epidemiology services must review their notification guidelines to ensure they apply the updated criteria.
• Coordination with health authorities: The Ministry of Health and the Health Departments of the Autonomous Communities are the channel for adaptation between the European framework and national systems. Health organizations must be alert to circulars and instructions issued by these bodies.
• Impact on the reporting chain to the ECDC: The data that Spain sends to the European Centre for Disease Prevention and Control must be adjusted to the amended definitions to maintain the comparability and quality of the European surveillance system.

Who does it affect?

• Spanish Ministry of Health and its epidemiological surveillance units (National Network for Epidemiological Surveillance, RENAVE).
• Health Departments of the 17 Autonomous Communities, responsible for epidemiological surveillance in their territory.
• Public and private hospitals with an obligation to report notifiable diseases.
• Clinical and public health laboratories that perform diagnostics of infectious diseases included in the European list.
• Health information systems (applications, platforms and databases) that manage case notification.
• Technology companies and health software providers that develop or maintain epidemiological surveillance systems for the public sector.

Practical example

A microbiology laboratory at a reference hospital detects a case of an infectious disease included in the list of Regulation 2026/2097. To report it correctly to the regional surveillance network—which in turn reports to the Ministry of Health and this to the ECDC—the laboratory must classify the case as "confirmed", "probable" or "possible" according to the current case definitions.

If the amendment published on 10 November 2026 modifies the case definition of that specific disease—for example, by adding or removing laboratory or clinical criteria—the laboratory that continues to apply the previous definition of Regulation 2026/2097 without incorporating the amendment will be reporting with outdated criteria. This can generate discrepancies in national and European data, affecting the quality of the EU's early warning system.

The immediate action is to verify with the corresponding regional health authority whether it has already issued instructions on the application of the amendment.

What should organizations do now?

1. Review the text of the official amendment published in the Official Journal of the EU (reference OJ:L_202690950) to identify exactly which definitions, lists or procedures have been modified.
2. Compare the changes with current internal protocols for epidemiological notification, especially in preventive medicine, microbiology and emergency services.
3. Contact the regional health authority to find out whether they have already issued adaptation instructions or if an update of regional information systems is planned.
4. Update health information systems that manage case notification, incorporating the amended definitions before they generate inconsistent data.
5. Train clinical and laboratory staff involved in the detection and notification of notifiable diseases on the updated criteria.
6. Document the adaptation process to demonstrate compliance in the event of possible audits or health inspections.

Official source

Consult complete regulation in official source

Disclaimer: This article is for informational purposes only and does not constitute legal advice. For specific decisions, consult a qualified professional. Source: https://eur-lex.europa.eu/./legal-content/AUTO/?uri=OJ:L_202690950